U.S. Auto Loan ABS Transactions Are Reaping The Benefits Of High Used Vehicle Values Jun 11

  • ID: 1834714
  • June 2011
  • Region: United States
  • Standard & Poors
1 of 2

The U.S. auto loan asset-backed securities (ABS) industry's performance has strengthened considerably since early 2009, and the unprecedented surge in used vehicle values has played a pivotal role in that success. As of May 2011, the Manheim Used Vehicle Value Index reached a record high of 127.8, up 5.6% from May 2010 and 17.1% from May 2009. As the market slowly emerges from the recession, the auto industry has also begun to recover, though it is still feeling the effects of the downturn. One positive offshoot of the production and sales declines we've seen since 2009 is the low used vehicle inventory, which continues to push used vehicle prices higher. In Standard & Poor's Ratings Services' view, this trend has...

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.